{"id":"NCT03214380","sponsor":"Eli Lilly and Company","briefTitle":"A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes","officialTitle":"A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-07-14","primaryCompletion":"2018-08-14","completion":"2019-03-13","firstPosted":"2017-07-11","resultsPosted":"2020-03-27","lastUpdate":"2020-03-27"},"enrollment":933,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"LY900014","otherNames":["Ultra-Rapid Lispro"]},{"type":"DRUG","name":"Insulin Lispro","otherNames":["Humalog"]},{"type":"DRUG","name":"Insulin Glargine","otherNames":[]},{"type":"DRUG","name":"Insulin Degludec","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"SGLT2 inhibitor","otherNames":[]}],"arms":[{"label":"LY900014","type":"EXPERIMENTAL"},{"label":"Insulin Lispro (Humalog)","type":"ACTIVE_COMPARATOR"},{"label":"LY900014 Maximum Extended Enrollment (MEE)","type":"EXPERIMENTAL"},{"label":"Insulin Lispro (Humalog) MEE","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare LY900014 to insulin lispro, both in combination with insulin glargine or insulin degludec, in participants with type 2 diabetes (T2D).","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (HbA1c) Efficacy Estimand at Week 26","timeFrame":"Baseline, Week 26","effectByArm":[{"arm":"Insulin Lispro (Humalog)","deltaMin":-0.43,"sd":0.042},{"arm":"LY900014","deltaMin":-0.38,"sd":0.042}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":141,"countries":["United States","Argentina","Australia","Czechia","Germany","Hungary","India","Italy","Japan","Mexico","Puerto Rico","Russia","Slovakia","South Korea","Spain","Taiwan"]},"refs":{"pmids":["38035641","35781789","32728833","32616612"],"seeAlso":["https://www.lillytrialguide.com/en-US/studies/type-2-diabetes/ITRN#?postal="]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":750},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Diarrhoea"]}}